Astera Labs (NASDAQ:ALAB) Upgraded to "Outperform" at Northland Securities

Key Points

• Northland Securities upgraded Astera Labs to “Outperform” from “Market Perform” and set a $350 price target, implying 8.83% upside from the prior close.
• Astera Labs reported stronger-than-expected quarterly results, with $0.80 EPS versus the $0.69 consensus and $392.4 million in revenue, up 104.5% year over year.
• Analyst sentiment remains favorable, with a “Moderate Buy” consensus rating and $333 average price target, although insiders have sold approximately $292.4 million of stock over the past three months.

Astera Labs (NASDAQ:ALAB - Get Free Report) was upgraded by investment analysts at Northland Securities from a "market perform" rating to an "outperform" rating in a report released on Monday,Benzinga reports. The firm currently has a $350.00 price objective on the stock. Northland Securities' target price indicates a potential upside of 8.83% from the stock's previous close.

ALAB has been the topic of a number of other research reports. Susquehanna raised their price target on Astera Labs from $230.00 to $275.00 and gave the company a "neutral" rating in a research report on Friday, July 31st. JPMorgan Chase & Co. boosted their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the stock an "overweight" rating in a report on Wednesday, May 6th. Stifel Nicolaus boosted their price target on shares of Astera Labs from $260.00 to $460.00 and gave the stock a "buy" rating in a research note on Wednesday, June 24th. Needham & Company LLC boosted their target price on Astera Labs from $260.00 to $425.00 and gave the company a "buy" rating in a research note on Wednesday, August 5th. Finally, Citigroup reiterated a "buy" rating on shares of Astera Labs in a research report on Wednesday, July 29th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $333.00.

Astera Labs Stock Performance

Shares of ALAB stock opened at $321.61 on Monday. The company has a market capitalization of $55.80 billion, a PE ratio of 159.21 and a beta of 3.84. Astera Labs has a 52-week low of $97.89 and a 52-week high of $499.48. The business's fifty day moving average is $358.00 and its 200 day moving average is $240.74.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to analysts' expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company's revenue was up 104.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts forecast that Astera Labs will post 2.7 EPS for the current fiscal year.

Insider Transactions at Astera Labs

In related news, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the transaction, the chief operating officer directly owned 5,064,213 shares of the company's stock, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the firm's stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the transaction, the director directly owned 75,688 shares of the company's stock, valued at $26,882,106.96. This represents a 11.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 940,716 shares of company stock worth $292,425,777. 10.40% of the stock is owned by insiders.

Hedge Funds Weigh In On Astera Labs

Several institutional investors and hedge funds have recently modified their holdings of ALAB. Atreides Management LP purchased a new position in Astera Labs in the second quarter worth about $587,736,000. Ausdal Financial Partners Inc. purchased a new position in shares of Astera Labs in the second quarter worth $807,000. Avenir Tech Ltd bought a new stake in Astera Labs in the 2nd quarter worth about $3,794,000. Bank of America Corp DE bought a new position in Astera Labs during the 2nd quarter valued at about $1,061,791,000. Finally, Light Street Capital Management LLC bought a new stake in shares of Astera Labs in the second quarter worth approximately $60,740,000. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source